UC TUR.WAR.OP.END. TRANSDIGM GROU.../ DE000HD34BU9 /
31/05/2024 21:40:28 | Var.-0.2000 | Denaro21:59:51 | Lettera21:59:51 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.6200EUR | -10.99% | 1.5400 Quantità in denaro: 20,000 |
1.5500 Quantità in lettera: 20,000 |
Transdigm Group Inco... | 1,505.1405 - | 31/12/2078 | Put |
GlobeNewswire
02:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering